Jimmy K. Limdi
ORCID: 0000-0002-1039-6251
· 1 paper in corpus
Introduction Despite advances in Ulcerative Colitis (UC) therapies, many patients suffer refractory symptoms in the absence of active inflammation. For this group, treatment remains challenging, with a paucity of therapeutic options. In thi…